Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Calidi Biotherapeutics (CLDI) just unveiled an announcement.
Calidi Biotherapeutics, Inc. has appointed Dr. George Peoples, a distinguished former military surgeon and esteemed academic, as a new board director and member of the Compensation Committee, effective July 1, 2024. With a background as a cancer research scientist and a history of leadership in various medical organizations, Dr. Peoples brings a wealth of expertise to the company’s board. His appointment, which will last until the 2025 annual stockholders’ meeting, includes standard indemnification and compensation as per company policy, with no disclosed conflicts of interest or family connections within the company’s current leadership.
Find detailed analytics on CLDI stock on TipRanks’ Stock Analysis page.